Khalid Shah

Khalid Shah

Harvard University

H-index: 55

North America-United States

About Khalid Shah

Khalid Shah, With an exceptional h-index of 55 and a recent h-index of 33 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Stem cells, Cancer, Immunology, Therapeutics, Brain tumors.

His recent articles reflect a diverse array of research interests and contributions to the field:

Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowding

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas

Locoregional delivery with engineered stem cells modulates immunosuppressive tumor microenvironment in brain leptomeningeal metastasis

Interrogating circadian clock compounds as an adjuvant to chemoradiation against GBM

Small molecule circadian clock compounds display therapeutic potential in targeting glioblastoma stem cells

Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors

An off-the-shelf Twin BiTE combination therapy controls heterogenous glioblastoma and shapes immune response

Khalid Shah Information

University

Position

Associate Professor Harvard Medical School

Citations(all)

11351

Citations(since 2020)

4733

Cited By

8049

hIndex(all)

55

hIndex(since 2020)

33

i10Index(all)

110

i10Index(since 2020)

93

Email

University Profile Page

Google Scholar

Khalid Shah Skills & Research Interests

Stem cells

Cancer

Immunology

Therapeutics

Brain tumors

Top articles of Khalid Shah

Title

Journal

Author(s)

Publication Date

Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowding

Science Translational Medicine

Pablo A Valdes

Chih-Chieh Yu

Jenna Aronson

Debarati Ghosh

Yongxin Zhao

...

2024/1/31

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Frontiers in Immunology

Longsha Liu

Thijs A van Schaik

Kok-Siong Chen

Filippo Rossignoli

Paulo Borges

...

2024/1/11

Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas

Clinical Cancer Research

Sung Hugh Choi

Daniel W Stuckey

Sara Pignatta

Clemens Reinshagen

Jasneet Kaur Khalsa

...

2024/5/1

Locoregional delivery with engineered stem cells modulates immunosuppressive tumor microenvironment in brain leptomeningeal metastasis

Cancer Research

Nobuhiko Kanaya

Waleed Seddiq

Kok-Siong Chen

Yoshinori Kajiwara

Lucia Moreno Lama

...

2024/3/22

Interrogating circadian clock compounds as an adjuvant to chemoradiation against GBM

Cancer Research

Priscilla Chan

Qiulian Wu

Anahit Hovsepyan

Seda Mkhitaryan

Gevorg Karapetyan

...

2024/3/22

Small molecule circadian clock compounds display therapeutic potential in targeting glioblastoma stem cells

Cancer Research

Priscilla Chan

Lian Wu

Anahit Hovsepyan

Seda Mkhitaryan

Gevorg Karapetyan

...

2023/4/4

Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors

Biomedicine & Pharmacotherapy

Thijs A Van Schaik

Lucia Moreno-Lama

Touraj Aligholipour Farzani

Mian Wang

Kok-Siong Chen

...

2023/6/1

An off-the-shelf Twin BiTE combination therapy controls heterogenous glioblastoma and shapes immune response

Cancer Research

Filippo Rossignoli

Paulo Borges

Rebecca Lumia

Khalid Shah

2023/4/4

Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases

Cancer Gene Therapy

Darshini Kuruppu

Deepak Bhere

Christian T Farrar

Khalid Shah

Anna-Liisa Brownell

...

2023/6

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus

Frontiers in Immunology

Almohanad A Alkayyal

Reham Ajina

Marco Cacciabue

Aaesha A Alkayyal

Nizar H Saeedi

...

2023/1/31

Gene-edited and-engineered stem cell platform drives immunotherapy for brain metastatic melanomas

Science translational medicine

Nobuhiko Kanaya

Yohei Kitamura

Maria Lopez Vazquez

Arnaldo Franco

Kok-Siong Chen

...

2023/5/31

Developing and characterizing a two-layered safety switch for cell therapies

Cancer Biology & Therapy

Filippo Rossignoli

Danielle Hoffman

Emaan Atif

Khalid Shah

2023/12/31

Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy

bioRxiv

Nihal Karakaş

Ozan Topcu

Erdem Tüzün

Özlem Timirci Kahraman

Pulat Akın Sabancı

...

2023/1/27

Engineered stem cells releasing oncolytic virus and immunomodulators have therapeutic efficacy in brain metastatic tumors

Khalid Shah

Nobuhiko Kanaya

Suman Srinivasa

Hiroaki Wakimoto

Kok Siong Chen

...

2023/5/11

Taming CAR T cell therapy toxicity

Nature Materials

C Liu

K Shah

2023/11/30

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

Science translational medicine

Kok-Siong Chen

Clemens Reinshagen

Thijs A Van Schaik

Filippo Rossignoli

Paulo Borges

...

2023/1/4

Developing a self-targeted cancer immunotherapy using engineered whole tumor cell-based vaccine

Cancer Research

Kok-Siong Chen

Natalia Claire Mendonca

Paulo Borges

Khalid Shah

2023/4/4

Meningeal lymphatics and their role in CNS disorder treatment: moving past misconceptions

Alexandra Melloni

Longsha Liu

Vivek Kashinath

Reza Abdi

Khalid Shah

2023/7/12

Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS

Longsha Liu

Jun R Huh

Khalid Shah

2022/3/1

The potential of the gut microbiome to reshape the cancer therapy paradigm: A review

Longsha Liu

Khalid Shah

2022/7/1

See List of Professors in Khalid Shah University(Harvard University)